Company news

GeneDx Holdings Corp. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

March 17, 2025

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

March 12, 2025

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

March 12, 2025

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

March 3, 2025

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

February 23, 2025

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

February 17, 2025

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

February 12, 2025

GeneDx to Participate in 45th Annual TD Cowen Health Care Conference

February 11, 2025

GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment

February 9, 2025

GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025

January 27, 2025

GeneDx Announces Preliminary 2024 Financial Results

January 12, 2025

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

January 8, 2025

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

January 7, 2025

GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer

January 1, 2025

GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 15, 2024

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

December 4, 2024

GeneDx to Participate in Upcoming Investor Conference

November 21, 2024

GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover

November 18, 2024

GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary

November 17, 2024

New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields

November 6, 2024

GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

November 3, 2024

GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights

October 28, 2024

Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening

October 23, 2024

GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns

October 7, 2024

GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024

October 2, 2024

GeneDx to Participate in Fall Investor Conferences

August 11, 2024

GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights

July 29, 2024

GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients

July 29, 2024

GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024

July 10, 2024

GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients

June 9, 2024

GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients

June 4, 2024

GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

April 28, 2024

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

April 22, 2024

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024

April 3, 2024

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

March 13, 2024

GeneDx to Participate in 44th Annual Cowen Health Care Conference

February 25, 2024

GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

February 19, 2024

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024

January 31, 2024

GeneDx Announces Preliminary 2023 Financial Results

January 7, 2024

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

November 30, 2023

GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference

November 27, 2023

GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights

October 29, 2023

GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023

October 8, 2023

GeneDx Announces Evolution of Executive Leadership Team

September 10, 2023

GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced

September 5, 2023

GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine

August 20, 2023

GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights

August 7, 2023

PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

August 6, 2023

GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options

July 18, 2023

GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

July 17, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 20 calls. Every call is listed under its year.

Decks

The 5 newest of 36 decks. Every deck is listed under its year.